Vaccine Type May Affect DTaP Adherence

Article

A poster at the virtual 2020 ID Week looked at how vaccine type can impact diphtheria, tetanus, and acellular pertussis (DTaP) vaccination.

Vaccine

Vaccine guidelines currently recommend the 3+1 diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series for infants and toddlers, but coverage and timeliness of receiving the vaccines continues to be at less than optimal levels in the United States. A poster presentation at the virtual 2020 ID Week presented the results of a study that compared coverage and timeliness between DTaP-containing combination vaccines (ie, quadrivalent/pentavalent) and stand-alone vaccines (ie, trivalent).1

The researchers developed a cohort of children who were born between 2009 and 2016 with >24 months of continuous enrollment from birth and a record of > 1 DTaP vaccine being administered. It was created using the Optum de-identified Clinformatics Data Mart database. The children were labelled by DTaP vaccine uptake: combination vaccines only, stand-alone vaccines only, or a mixture of both. Primary outcome for the study was completing a 4-dose series of DTaP by the time the patient was 20 months of age.

The cohort included 412,450 children, comprised of 200,568 girls (48.6%) and 211,882 boys (51.4%). Among these children, 167,091 were administered only combination vaccines; 61,342 children received the stand-alone vaccine only; and 184,017 members of the cohort were administered a mixture of stand-alone and combination vaccine doses. The researchers found that the completion of the 4-dose series was highest in children who had only received the combination vaccine (75.5%).

Read the full article on Contemporary Pediatrics.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Image Credit: anidimi - stock.adobe.com
Image Credit: เลิศลักษณ์ ทิพชัย - stock.adobe.com
Image Credit: trsakaoe - stock.adobe.com
Image Credit: Alex Photo - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.